Stock Report

Jubilant Pharmova Ltd consolidated Q1 FY25 PAT surges to Rs. 482.1 crores

Posted On : 2024-07-20 19:32:56( TIMEZONE : IST )

Jubilant Pharmova Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 1745.7 crores during the period ended June 30, 2024 as compared to Rs. 1773 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 482.1 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. -58.6 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 30.35 for the period ended June 30, 2024 as compared to Rs. -3.68 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 1745.7 crs	₹1773 crs	-1.54%
Net Profit	₹482.1 crs	₹-58.6 crs	922.70%
EPS	₹30.35	₹-3.68	924.73%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 1745.7 crores during the period ended June 30, 2024 as compared to Rs.1595.5 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.482.1 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.6.4 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.30.35 for the period ended June 30, 2024 as compared to Rs.0.40 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 1745.7 crs	₹1595.5 crs	9.41%
Net Profit	₹482.1 crs	₹6.4 crs	7,432.81%
EPS	₹30.35	₹0.40	7,487.50%

Shares of Jubilant Pharmova Limited was last trading in BSE at Rs. 752.25 as compared to the previous close of Rs. 726.95. The total number of shares traded during the day was 140442 in over 8683 trades.

The stock hit an intraday high of Rs. 799.95 and intraday low of 701.40. The net turnover during the day was Rs. 106881276.00.